Two independent reviewers is good. I would like to know the training of the reviewers, in general and as it relates to the protocol. Are they cardiologists, radiologists, or high school students? Who trained them on the protocol and did they do any preliminary training/testing to ensure reliability and a mutual shared mental model?
If no language restriction was applied, what did the authors do if they identified a study that was not in a language spoken by the authors?
Please clarify how the "pre-defined data extraction sheet" was made and who determined what went into it. Was it modified through the process or did it stay the same? Historically when I have done studies like this, I have decided to add data to the extraction sheet part way through the process, which, to some, could compromise integrity of the study.
In Line 66, P is lower case In line 69, I am not sure what the authors are referring to as the "false positive rate" but it is unclear here. The log of 1-specificity is not the false positive rate.
Line 73 has a typographical error with some abnormal figure between PLR and negative likelihood ratio. Then, negative has (PLR) after it when NLR should be after "negative likelihood ratio" and PLR should not be repeated.
Please clarify what type of weighting was done for the studies. Inverse variance? Strict sample size? random or fixed effect?
Results: PRISMA diagram is present. See below for comments on figures and tables.
In lines 91-101 please provide citations for the studies using each method. When the authors say "majority" they should list xx/xx, xx% and then provide citations. Citations should be on each of these sentences/references. Line 126, again, needs some punctuation.
The last sentence in lines 137-138 does not seem to fit with the rest of the paragraph. The paragraph is about various pressure gradient cutoffs, then the last sentence is about TRPG overall. Can the authors either remove this or help provide some transition to make it fit here better?
Discussion:
Overly long and could be shortened by about 1/3. Again, please review English, grammar, and formatting in the discussion. (i.e. " . . . studies of using IVC. . . ", " . . .diagnostic effect was general", etc.)
No need to repeat the results, per se, in the discussion. The first sentence should suffice. You may even add the numbers parenthetically, but then you can save the redundant sentence.
Line 155-156 --the authors are overly representative of the meaning of their work "Adamant evidence" is WAY too strong of a term for this much heterogeneity. I would say that there is a lot of heterogeneity and that limits our results. Then, stop there. I think this is a good paper and will add to the literature, but a common and potentially major downfall of this type of paper is overemphasis on the results.
Lines 164-169 is difficult to understand and should be rephrased with clearer language. I like that this section is here. It will just need to be worded clearer. "we must face up" is a little informal for this type of paper.
Line 178-180 is a run-on. And subsequent sentences need rewording.
Does the diagnostic test and REFERENCE test affect the diagnostic accuracy is an overly broad question and I would argue that there is consensus that this does affect some tests. Also, It is too broad of a question. Focus n the topic of this SR, as you do in subsequent sentences and remove this generalization.
In limitations: Again, review English language. Operator dependence/training must be included in diagnostic accuracy studies of ultrasound. Systematic reviews, too, should list the possibility of missing potentially relevant articles as a potential limitation. For this study, in particular, the significant heterogeneity limits result interpretation/generalizability. "ultrasonic" is not the term generally used to describe equipment used for medical ultrasonography Conclusion: Again, the authors overstate their results. "The value. . . is certain." The authors even go on to acknowledge that more studies are needed. The clause "and appropriate cut-off threshold" is out of place and confusing.
References:
These are not formatted consistently. Be mindful of when or when not to use abbreviations, capitalizations, and punctuation. There are many references with unnecessary indentations/spaces.
When citing more than one article at a time, it is customary to place them in alphabetical order.
I typically attempt to check 10% of references for accuracy. Mostly accurate except: Reference 2 is incorrectly cited. While it does note aging population it is cited as also noting that PH will become a global health problem, which it does not state anywhere I can find. Reference 3 does not show that early diagnosis improves outcome. there are many studies that do this, but not the one cited. Given these were found and I did not check all references, I would surmise that other issues like this exist. I would encourage the authors to carefully review their references to ensure accurate citations.
Tables and Figures:
There are many of them, but I think they are additive and needed for this type of publication.
Titles should be descriptive enough to stand alone. For example, Table 1 ". . . . in this Meta-analysis" is not specific enough. " . . . in a meta analysis of . . ." would be better. Table 3 "Sensitivity Analysis" needs more detail. etc.
Tables -Please check for formatting errors. There are a couple places where they are misaligns or have extra spaces. This can be very difficult to do with large tables in a Word document, but it is important.
Also, you do have to spell out all abbreviations, (USA, UK) in all table/figure legends and have to respell them for each legend (e.g. SPAP)
PRISMA Diagram -Normally the "records identified through other reviews" appears lower on the chart" I suspect there were many more records in other reviews that the authors had already obtained through their search and discarded. IT therefore doesn't make sense to imply that these "other" records went through a "de-duplication" process as that was likely done prior to identifying these 13. Further, there is no box "out" indicating duplicates removed. In "full text articles excluded" box, the number should be 58, I believe, and not 56.
Forrest Plot -How does the Forrest plot indicate n=28 when the PRISMA diagram states n=27? Where did this extra study come from? Penning or the division of Habash? Is it or is it not included? This should be clear on the PRISMA diagram as many readers will focus on these and will be confused as to why one says 27 and the other says 28.
Thank you again for allowing me to review this paper. I have made many suggestions for improvement to this paper. The biggest limitation to this paper's success at this time is it's English, grammar, and formatting. There are many sentences that I cannot understand in their current form and cannot therefore fully evaluate this paper. It seems on the surface that, while there are some minor places of improvement, that the methodology itself is relatively sound and consistent with printed guidelines. I would encourage the authors to work on re-writing the paper, with assistance if needed, to help make this science into a great publication to share with the scientific community.
REVIEWER
Adaani Frost Houston Methodist Institute of Academic Medicine, USA REVIEW RETURNED 11-Aug-2019
GENERAL COMMENTS
Diagnostic value of transthoracic echocardiography for pulmonary hypertension : a systematic review and meta-analysis.
Summary:
The authors undertook an extensive literature review identifying from literature and study databases 27 studies including 4386 unique pulmonary hypertensive (PH) patients undergoing transthoracic echocardiogram (TTE) and right heart catheterization (RHC) to determine the reliability (sensitivity,specificity, negative and positive likelihood rations, pooled diagnostic odds ration and area under the summary receiver operating curve[SROC]) of TTE in diagnosing PH. They conclude that the value of TTE in diagnosing PH is "certain" although it cannot replace RHC as the gold standard. They also demonstrated that the time between TTE and RHC and disease composition ( specifically the presence of interstitial lung disease) affected the correlation of RHC and TTE and the diagnostic value of TTE. Comments:
The value of this study is that it is one of the most extensive metaanalyses done. The driving rationale for this analysis was that echocardiography has advanced greatly as a science in more recent years offering the potential for greater sensitivity and specificity. The downside is that, in spite of this expectation prior meta-analyses have arrived at similar conclusions: that TTE is very useful, particularly as a screening tool, but does not replace RHC for diagnosis. In fact the sensitivity and specificity reported in those prior meta-analyses are not clinically importantly different from those reported by these authors. This does not however negate the utility of this analysis particularly in the context of the conclusion by World Symposium of Pulmonary Hypertension that PA mean pressures >20 are clearly abnormal and associated worse outcome.
MAJOR:
1) The discussion about the appropriateness of the new WSPH definition of PH which recognized that worsening patient mortality begins at PA pressure > 20 is outside the purview of this paper given that the authors did not do a meta-analysis with sensitivity and specifity, NPV, PPV or ROC for this definition of PH. In fact probably given their introduction and their concluding remarks about utility of echo in PH diagnosis by this definition , it is surprising that they did not undertake an analysis of the utility of current echo modalities using this defintion. THAT WOULD HAVE BEEN A VERY IMPORTANT PAPER. I do agree that though PA mean pressure elevation > 20 ( by RHC) is clinically important, the likelihood that use of echo for screening /diagnosis for this modified definition of PH may be limitedhowever that supposition is purely speculative and not addressed by this data therefore not germane to their review.
2) The extensive evaluation the authors did which was predicated on the expectation that more recent data analyses using modern methods for measurements of PA systolic pressure would show a substantially improved diagnostic accuracy. There data and conclusion is basically that surprisingly given the evolution of techniques for more accurate determination of PA systolic, such diagnostic accuracy is not significanlty more reliable than 10 year ago. A reasonable conclusion might be that perhaps for future screening and diagnosis, we should focus on some other echocardiographic indicator of PH (other that TR jet)for example, some other index of RV overload…. If we keep looking at the same thing and with 20 years of experience and technological advances, echo is no more accurate for PH identification now than then, perhaps we are looking at the wrong index of possible PH.
Possibly that should be a conclusion . While outside the purview of these authors extensive efforts, this might prove useful for subsequent meta-analyses.
Minor: I think that the concluding statement of the abstract is somewhat overstated. "The value of TTE in diagnosing PH is certain, although it cannot yet replace RHC as the gold standard at this stage" Though this may be semantics I think someone reading the first part of the sentence would conclude that TTE is a suitable diagnostic tool, when in fact the authors conclusion is really that 'even with improvements in technique, technology and assessment tools, the utility of TTE in diagnosis of PH has not improved relative to prior eras and that though a valuable screening tool it cannot replace RHC'or as they say in their discussion : "TTE has clinical value for diagnosing PH." Line 146
Line 18-19 the referenced articles concluded that TTE was a useful screening tool. The use of the word "crude" to modify the utility was not included in the papers.
VERSION 1 -AUTHOR RESPONSE
Reviewer: 1 1. Title: Appropriate length and description. "Diagnostic accuracy" is probably more appropriate than "Diagnostic value". Thanks for your suggestion. We have modified it. 2. Abstract: Please spell out all abbreviations at first use in both abstract and manuscript. The term "diagnostic accuracy" might be more appropriate than diagnostic value, which implies some clinical weighting to the results. "The value. . . is certain" is overly strong for this level of evidence. Thanks for your suggestions. We have checked all the acronyms to make sure that they were defined at first use in both abstract and manuscript. The "diagnostic value" has been changed to "diagnostic accuracy". The conclusion has also been modified. 3. Intro: Please have someone review English/writing in this section for contextual/usage errors. There are many (i.e. "aggravation of population aging", comma use, etc.). This introduction appears too long and basic. The authors do not need to describe "an ideal evidence system" and what a metaanalysis is to readers. Please clarify primary outcome and that "factors that may affect diagnostic accuracy" is a secondary or even exploratory hypothesis. Note here and throughout the paper that in text superscript references go outside commas and periods and inside colons and semi-colons. Thanks for your suggestion. We have modified the introduction and removed unnecessary content. The manuscript have been polished by a native English-speaking editor of MogoEdit, which is a professional English editing company. The citation has been modified accordingly.
Methods
(1) Two independent reviewers is good. I would like to know the training of the reviewers, in general and as it relates to the protocol. Are they cardiologists, radiologists, or high school students? Who trained them on the protocol and did they do any preliminary training/testing to ensure reliability and a mutual shared mental model. (2) If no language restriction was applied, what did the authors do if they identified a study that was not in a language spoken by the authors? If a study we identified is not conducted in the author's language, professional translation software could be used to help us reading. This has been supplemented in the manuscript (Line 40-41).
(3) Please clarify how the "pre-defined data extraction sheet" was made and who determined what went into it. Was it modified through the process or did it stay the same? Historically when I have done studies like this, I have decided to add data to the extraction sheet part way through the process, which, to some, could compromise integrity of the study. The pre-defined data extraction sheet was made by all authors in consultation according to the references. Next, we used five related articles to pre-extract the data for improving our data extraction sheet. It was determined before registration and remained unchanged during the implementation of the study. (4) In Line 66, P is lower case. Thanks for your suggestion. We have modified it accordingly. (5) In line 69, I am not sure what the authors are referring to as the "false positive rate" but it is unclear here. The log of 1-specificity is not the false positive rate. Thanks for your suggestion. In order to avoid ambiguity, the contents of the brackets have been deleted.
(6) Line 73 has a typographical error with some abnormal figure between PLR and negative likelihood ratio. Then, negative has (PLR) after it when NLR should be after "negative likelihood ratio" and PLR should not be repeated. Thanks for your suggestion. We have modified it accordingly. (7) Please clarify what type of weighting was done for the studies. Inverse variance? Strict sample size? Random or fixed effect? To our knowledge, when the data synthesis and statistical analysis of diagnostic meta-analysis is conducted by the Metadisc software, we can select random effect model, fixed effect model, weighting and et al. However, STATA software was chosen in our study. The STATA uses a bivariate mixed effect model to perform data synthesis and statistical analysis of diagnostic meta-analysis.
Results
(1) In lines 91-101 please provide citations for the studies using each method. When the authors say "majority" they should list xx/xx, xx% and then provide citations. Citations should be on each of these sentences/references. Thanks for your suggestion. We have modified it accordingly.
(2) Line 126, again, needs some punctuation. Thanks for your suggestion. We have modified it accordingly.
(3) The last sentence in lines 137-138 does not seem to fit with the rest of the paragraph. The paragraph is about various pressure gradient cutoffs, then the last sentence is about TRPG overall. Can the authors either remove this or help provide some transition to make it fit here better? Thanks for your suggestion. We deleted this sentence accordingly.
Discussion
(1) Overly long and could be shortened by about 1/3. Thanks for your suggestion. After repeated consultation of all authors, the discussion part of our manuscript has been revised and shortened.
(2) Again, please review English, grammar, and formatting in the discussion. (i.e. " . . . studies of using IVC. . . ", " . . .diagnostic effect was general", etc.) Thanks for your suggestion. We have modified this section.
(3) No need to repeat the results, per se, in the discussion. The first sentence should suffice. You may even add the numbers parenthetically, but then you can save the redundant sentence. Thanks for your suggestion. We have modified it accordingly.
(4) Line 155-156 --the authors are overly representative of the meaning of their work "Adamant evidence" is WAY too strong of a term for this much heterogeneity. I would say that there is a lot of heterogeneity and that limits our results. Then, stop there. I think this is a good paper and will add to the literature, but a common and potentially major downfall of this type of paper is overemphasis on the results. Thanks for your suggestion. This part about heterogeneity has been divided into two parts and added to the results part and the limitations part respectively. (5) Lines 164-169 is difficult to understand and should be rephrased with clearer language. I like that this section is here. It will just need to be worded clearer. "we must face up" is a little informal for this type of paper. Thanks for your suggestion. This part has been modified. (6) Line 178-180 is a run-on. And subsequent sentences need re-wording. Thanks for your suggestion. We have modified it accordingly. (7) Does the diagnostic test and REFERENCE test affect the diagnostic accuracy is an overly broad question and I would argue that there is consensus that this does affect some tests. Also, it is too broad of a question. Focus on the topic of this SR, as you do in subsequent sentences and remove this generalization. Thanks for your suggestion. We removed this generalization statement and focused on a subgroup analysis of TTE thresholds. 7. In limitations: Again, review English language. Operator dependence/training must be included in diagnostic accuracy studies of ultrasound. Systematic reviews, too, should list the possibility of missing potentially relevant articles as a potential limitation. For this study, in particular, the significant heterogeneity limits result interpretation/generalizability. "Ultrasonic" is not the term generally used to describe equipment used for medical ultrasonography. Thanks for your suggestion. We have added the two points you mentioned to the limitation part. 8. Conclusion: Again, the authors overstate their results. "The value. . . is certain." The authors even go on to acknowledge that more studies are needed. The clause "and appropriate cut-off threshold" is out of place and confusing. Thanks for your suggestion. The conclusion has also been modified as required. 9. References (1) These are not formatted consistently. Be mindful of when or when not to use abbreviations, capitalizations, and punctuation. There are many references with unnecessary indentations/spaces. Thanks for your suggestion. We have modified the reference format accordingly.
(2) When citing more than one article at a time, it is customary to place them in alphabetical order. Thanks for your suggestion. We have modified it accordingly.
(3) I typically attempt to check 10% of references for accuracy. Mostly accurate except: Reference 2 is incorrectly cited. While it does note aging population it is cited as also noting that PH will become a global health problem, which it does not state anywhere I can find. Reference 3 does not show that early diagnosis improves outcome. there are many studies that do this, but not the one cited. Given these were found and I did not check all references, I would surmise that other issues like this exist. I would encourage the authors to carefully review their references to ensure accurate citations. Thanks for your suggestion. We have rechecked the cited references to ensure the accuracy of the citations.
Tables and Figures
(1) Titles should be descriptive enough to stand alone. For example, Table 1 ". . . . in this Metaanalysis" is not specific enough. " . . . in a meta analysis of . . ." would be better. Table 3 "Sensitivity Analysis" needs more detail. etc. Thanks for your suggestion. We have modified it accordingly.
(2) Tables -Please check for formatting errors. There are a couple places where they are misaligns or have extra spaces. This can be very difficult to do with large tables in a Word document, but it is important. Thanks for your suggestion. We have modified it accordingly.
(3) Also, you do have to spell out all abbreviations, (USA, UK) in all table/figure legends and have to respell them for each legend (e.g. SPAP). Thanks for your suggestion. We have added missing abbreviations in all the legends. (4) PRISMA Diagram -Normally the "records identified through other reviews" appears lower on the chart" I suspect there were many more records in other reviews that the authors had already obtained through their search and discarded. IT therefore doesn't make sense to imply that these "other" records went through a "de-duplication" process as that was likely done prior to identifying these 13. Further, there is no box "out" indicating duplicates removed. In "full text articles excluded" box, the number should be 58, I believe, and not 56. Thanks for your suggestion. We have re-created the PRISMA Diagram as required, and corrected the error that existed in "full text articles excluded" box. This should be clear on the PRISMA diagram as many readers will focus on these and will be confused as to why one says 27 and the other says 28. Thanks for your suggestion. In order not to be confused by the reader, we added a comment at the end of the PRISMA Diagram. We include 27 publications, but the study of Habash was divided into two independent parts because of the differences between the case group and the control group. So we got 28 sets of data for analysis finally. Reviewer: 2 MAJOR (1) The discussion about the appropriateness of the new WSPH definition of PH which recognized that worsening patient mortality begins at PA pressure > 20 is outside the purview of this paper given that the authors did not do a meta-analysis with sensitivity and specifity, NPV, PPV or ROC for this definition of PH. In fact probably given their introduction and their concluding remarks about utility of echo in PH diagnosis by this definition, it is surprising that they did not undertake an analysis of the utility of current echo modalities using this defintion. THAT WOULD HAVE BEEN A VERY IMPORTANT PAPER. I do agree that though PA mean pressure elevation > 20 ( by RHC) is clinically important, the likelihood that use of echo for screening /diagnosis for this modified definition of PH may be limited however that supposition is purely speculative and not addressed by this data therefore not germane to their review. Thanks for your suggestion. Our original purpose was to conduct subgroup analysis on the two thresholds of 20mmHg and 25mmHg, but we found that none of the study we included used MPAP>20mmHg as the diagnostic threshold for RHC. Finally, the sensitivity analysis based on the MPAP threshold of 25mmHg did not result in a higher diagnostic value than the whole. Therefore, we expect that more studies may be conducted in the future to verify the appropriate threshold of RHC.
(2) The extensive evaluation the authors did which was predicated on the expectation that more recent data analyses using modern methods for measurements of PA systolic pressure would show a substantially improved diagnostic accuracy. There data and conclusion is basically that surprisingly given the evolution of techniques for more accurate determination of PA systolic, such diagnostic accuracy is not significantly more reliable than 10 year ago. A reasonable conclusion might be that perhaps for future screening and diagnosis, we should focus on some other echocardiographic indicator of PH (other than TR jet) for example, some other index of RV overload. If we keep looking at the same thing and with 20 years of experience and technological advances, echo is no more accurate for PH identification now than then, perhaps we are looking at the wrong index of possible PH. Possibly that should be a conclusion. While outside the purview of these authors extensive efforts, this might prove useful for subsequent meta-analyses. Thanks for your suggestion. The question you mentioned is very valuable for us. We have supplemented these in the section of discussion and conclusion (Line 181-183, 199-201). MINOR (2) I think that the concluding statement of the abstract is somewhat overstated. The value of TTE in diagnosing PH is certain, although it cannot yet replace RHC as the gold standard at this stage Though this may be semantics I think someone reading the first part of the sentence would conclude that TTE is a suitable diagnostic tool, when in fact the authors conclusion is really that even with improvements in technique, technology and assessment tools, the utility of TTE in diagnosis of PH has not improved relative to prior eras and that though a valuable screening tool it cannot replace RHC or as they say in their discussion: TTE has clinical value for diagnosing PH. Line 146. Thanks for your suggestion. We have modified the conclusion accordingly.
(2) Line 18-19 the referenced articles concluded that TTE was a useful screening tool. The use of the word crude to modify the utility was not included in the papers. Thanks for your suggestion. We have modified it. 
GENERAL COMMENTS
Thank you for again allowing me to again review the revision of this manuscript. It is much improved. The English is much more understandable, and overall it has all of the hallmarks of a well written systematic review and meta-analysis. I offer some minor suggestions for improvement inn each section below.
Title: Improved.
Abstract: Good. It should be able to stand alone, though. In the Conclusion the statements "The accuracy of TTE may be improved by shortening the time interval between TTE and RHC and by developing an appropriate threshold. TTE may not be suitable to assess pulmonary arterial pressure in patients with pulmonary diseases." are not described in the results of the abstract well enough to make them eligible to be stated as conclusions.
Introduction: Good. It would be better if the authors could cite primary literature in place of the review cited in reference 2 about improved outcomes.
Methods: Well written. This study is done in a manner typical and adequate for a systematic review and uses appropriate guideline (PRISMA) and is registered (PROSPERO). They utilize or describe why they did not utilize all key aspects for systematic review.
Can the authors clarify whether subgroups were determined a priori or not? On a minor point, an inclusion criteria does not also have to be an exclusion criteria (using tricuspid regurgitation). One or the other will suffice.
Results: Described well. On another minor point, right atrial pressure is spelled out after it is used (in the equation). It flows well as it is but is not technically ideal. It would be nice if the authors could write some overall statement about quality in the quality assessment section aside from describing each part. I struggler with the statement that the cutoff of 35mmHg was superior to 40mmHg. I think a balance of sensitivity and specificity has to take in other variables like use, availability, and implication of a positive and negative test. One could argue that "overall" performance is superior, but I might encourage the authors to find a way to describe this without using the term "superior".
Discussion: Well written Limitations: Covers most major limitations. One of the additions has a typographical error "In order to obtain more original studies, we did not strictly controlled this aspect." should be "control for" or even better "use this as an exclusion". Conclusion: Well done.
References: I checked 10 random references and found them to be cited correctly, including 3 included in the analysis. They were found to be cited correctly, noting that I cannot check all of the pooled results without redoing all of their data analysis and having access to all of their data. There are several inconsistencies in formatting, that the authors would be prudent to re-check (capitalization, punctuation, use of leading numbers in pages, etc.).
Figures/Tables:
Titles of figures and tables need to be detailed enough to stand alone.
In the legend in table 1, "NR" is listed as "not report", where "not reported" would be better. Also in table 1, the authors might use "mo" as the abbreviation for month so as not to confuse it with minute.
I am aware of 1 review (not a systematic review) that has come out since prior review of this Cordina et al. State-of-the-Art Review: Echocardiography in Pulmonary Hypertension. Heart Lung Circulation. The authors may consider checking of this new review to make sure that they did not miss any potentially germane studies. This may sound easy, but as an author of many studies of this type, it can seem like a never-ending cycle to keep the systematic review up to date, so I would certainly not consider this mandatory, especially in light of their year restriction to 6/2019 clearly outlined in the paper.
In summary, this article is high quality and very relevant. I think the authors can make some minor changes to make it even better. I am excited to see this article in the process towards publication.
VERSION 2 -AUTHOR RESPONSE
Reviewer: 1 1. Abstract: Good. It should be able to stand alone, though. In the Conclusion the statements "The accuracy of TTE may be improved by shortening the time interval between TTE and RHC and by developing an appropriate threshold. TTE may not be suitable to assess pulmonary arterial pressure in patients with pulmonary diseases." are not described in the results of the abstract well enough to make them eligible to be stated as conclusions. Thanks for your suggestion. We have added the results of the subgroup analysis to the abstract to support the conclusion. 2. Introduction: Good. It would be better if the authors could cite primary literature in place of the review cited in reference 2 about improved outcomes. Thanks for your suggestion. We have cited a primary study to instead the original cited review : Galie
